Simon Moore discusses non-clinical development channels: technical strategies, formulations and devices. Conventionally, inhaled drugs have been used to deliver medicines targeted at the most ...

- The Company was incorporated on 18th, November, as "Glenmark Pharmaceuticals Private Limited" under the Companies Act, 1956, and became a deemed Public Company on July 1, 1990, then again became a ...

Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate) – sold ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Lea Uradu, J.D., is a Maryland state registered tax preparer, state-certified notary public, ...

Kelly-Ann Franklin has spent more than two decades in journalism which has helped her build a wide knowledge base of business and personal finance topics. Her goal with editing is to ensure tough ...

You'll choose either the Coalition Application (powered by Scoir) or the Common Application. We encourage each applicant to express their unique personality and diverse array of life experiences ...

Thank you for your interest in the Johns Hopkins MD Programs! We'd love to share more information about our programs, and also get to know a little more about you. Applications for admission begin ...

Subscribe to receive updates of new development applications in a specific Toronto ward. Some closed applications may not appear on the Application Information Centre. For information about closed ...

Ethan's been a frequent flier for as long as he can remember, from studying abroad in Paris to moving to Shanghai after graduating college, where he served as TPG's eyes and ears for all things travel ...

If you are interested in receiving emails alerting you to new job postings, you can use the ‘Create Alert’ option. To set up the alert: You can view/edit job alerts by logging into your account and ...

(GSK) application for exclusive marketing rights for Avandia, an anti-diabetic drug for type-2 diabetes, which is owned by the firm's British parent -Pulls Ranbaxy, Novartis and others to court for ...